These observations support the role of GPER in the RhoA-mediated regulation of the mechanical properties of the tumor microenvironment of HCC cells as reported [157] and thus present RhoA as a promising target in the GPER-mediated pharmacological treatment of these cancers. The gene discussed is RHOA; the disease is cancer.